Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: An in vitro evaluation

Martina Anton, Constanze Wittermann, Roland Haubner, Marcus Simoes, Sybille Reder, Bryan Essien, Bettina Wagner, Julia Henke, Wolf Erhardt, Steffi Noll, Neil R. Hackett, Ronald Crystal, Markus Schwaiger, Bernd Gansbacher, Frank M. Bengel

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Coexpression of a reporter gene and a therapeutic gene may allow for noninvasive monitoring of cardiac gene therapy. We sought to evaluate the usefulness of an adenoviral vector expressing mutant herpesviral thymidine kinase reporter gene (HSV1-sr39tk) and vascular endothelial growth factor (VEGF) 121 in independent expression cassettes (Ad4tk). Methods: Accumulation of 14C-2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FIAU) and 9-(4-18F-fluoro-3-hydroxymethylbutyl)guanine (FHBG) as reporter probes, and secretion of VEGF into medium, were determined for Ad4tk-infected H9c2 rat cardiac cells in vitro. Results: In vitro tracer uptake increased with increasing vector concentration and over time. It was comparable to cells infected with adenovirus expressing only wild-type HSV1-tk (reporter probe: 14C-FIAU) or mutant HSV1-sr39tk (reporter probe: 18F-FHBG) . No significant uptake was observed in cells infected with adenovirus expressing VEGF alone. With increasing vector concentration, Ad4tk-infected cells increasingly released VEGF into medium. VEGF production correlated significantly with cellular reporter probe uptake (r = 0.93; P = 0.0003). Conclusion: The usefulness of a vector coexpressing HSV1-tk and VEGF for noninvasive imaging of expression of a therapeutic transgene has been demonstrated in vitro. This approach may allow for future in vivo monitoring of cardiac angiogenesis gene therapy.

Original languageEnglish
Pages (from-to)1743-1746
Number of pages4
JournalJournal of Nuclear Medicine
Volume45
Issue number10
Publication statusPublished - 1 Oct 2004
Externally publishedYes

Fingerprint

Thymidine Kinase
Reporter Genes
Vascular Endothelial Growth Factor A
Genes
Adenoviridae
Genetic Therapy
Arabinofuranosyluracil
Therapeutics
Guanine
Transgenes
In Vitro Techniques

Keywords

  • Gene therapy
  • Heart
  • Hsv1-tk
  • Reporter genes
  • VEGF

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Anton, M., Wittermann, C., Haubner, R., Simoes, M., Reder, S., Essien, B., ... Bengel, F. M. (2004). Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: An in vitro evaluation. Journal of Nuclear Medicine, 45(10), 1743-1746.

Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer : An in vitro evaluation. / Anton, Martina; Wittermann, Constanze; Haubner, Roland; Simoes, Marcus; Reder, Sybille; Essien, Bryan; Wagner, Bettina; Henke, Julia; Erhardt, Wolf; Noll, Steffi; Hackett, Neil R.; Crystal, Ronald; Schwaiger, Markus; Gansbacher, Bernd; Bengel, Frank M.

In: Journal of Nuclear Medicine, Vol. 45, No. 10, 01.10.2004, p. 1743-1746.

Research output: Contribution to journalArticle

Anton, M, Wittermann, C, Haubner, R, Simoes, M, Reder, S, Essien, B, Wagner, B, Henke, J, Erhardt, W, Noll, S, Hackett, NR, Crystal, R, Schwaiger, M, Gansbacher, B & Bengel, FM 2004, 'Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: An in vitro evaluation', Journal of Nuclear Medicine, vol. 45, no. 10, pp. 1743-1746.
Anton, Martina ; Wittermann, Constanze ; Haubner, Roland ; Simoes, Marcus ; Reder, Sybille ; Essien, Bryan ; Wagner, Bettina ; Henke, Julia ; Erhardt, Wolf ; Noll, Steffi ; Hackett, Neil R. ; Crystal, Ronald ; Schwaiger, Markus ; Gansbacher, Bernd ; Bengel, Frank M. / Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer : An in vitro evaluation. In: Journal of Nuclear Medicine. 2004 ; Vol. 45, No. 10. pp. 1743-1746.
@article{035969c9b0494e7b9bbe19642bdc215e,
title = "Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: An in vitro evaluation",
abstract = "Coexpression of a reporter gene and a therapeutic gene may allow for noninvasive monitoring of cardiac gene therapy. We sought to evaluate the usefulness of an adenoviral vector expressing mutant herpesviral thymidine kinase reporter gene (HSV1-sr39tk) and vascular endothelial growth factor (VEGF) 121 in independent expression cassettes (Ad4tk). Methods: Accumulation of 14C-2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FIAU) and 9-(4-18F-fluoro-3-hydroxymethylbutyl)guanine (FHBG) as reporter probes, and secretion of VEGF into medium, were determined for Ad4tk-infected H9c2 rat cardiac cells in vitro. Results: In vitro tracer uptake increased with increasing vector concentration and over time. It was comparable to cells infected with adenovirus expressing only wild-type HSV1-tk (reporter probe: 14C-FIAU) or mutant HSV1-sr39tk (reporter probe: 18F-FHBG) . No significant uptake was observed in cells infected with adenovirus expressing VEGF alone. With increasing vector concentration, Ad4tk-infected cells increasingly released VEGF into medium. VEGF production correlated significantly with cellular reporter probe uptake (r = 0.93; P = 0.0003). Conclusion: The usefulness of a vector coexpressing HSV1-tk and VEGF for noninvasive imaging of expression of a therapeutic transgene has been demonstrated in vitro. This approach may allow for future in vivo monitoring of cardiac angiogenesis gene therapy.",
keywords = "Gene therapy, Heart, Hsv1-tk, Reporter genes, VEGF",
author = "Martina Anton and Constanze Wittermann and Roland Haubner and Marcus Simoes and Sybille Reder and Bryan Essien and Bettina Wagner and Julia Henke and Wolf Erhardt and Steffi Noll and Hackett, {Neil R.} and Ronald Crystal and Markus Schwaiger and Bernd Gansbacher and Bengel, {Frank M.}",
year = "2004",
month = "10",
day = "1",
language = "English",
volume = "45",
pages = "1743--1746",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "10",

}

TY - JOUR

T1 - Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer

T2 - An in vitro evaluation

AU - Anton, Martina

AU - Wittermann, Constanze

AU - Haubner, Roland

AU - Simoes, Marcus

AU - Reder, Sybille

AU - Essien, Bryan

AU - Wagner, Bettina

AU - Henke, Julia

AU - Erhardt, Wolf

AU - Noll, Steffi

AU - Hackett, Neil R.

AU - Crystal, Ronald

AU - Schwaiger, Markus

AU - Gansbacher, Bernd

AU - Bengel, Frank M.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Coexpression of a reporter gene and a therapeutic gene may allow for noninvasive monitoring of cardiac gene therapy. We sought to evaluate the usefulness of an adenoviral vector expressing mutant herpesviral thymidine kinase reporter gene (HSV1-sr39tk) and vascular endothelial growth factor (VEGF) 121 in independent expression cassettes (Ad4tk). Methods: Accumulation of 14C-2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FIAU) and 9-(4-18F-fluoro-3-hydroxymethylbutyl)guanine (FHBG) as reporter probes, and secretion of VEGF into medium, were determined for Ad4tk-infected H9c2 rat cardiac cells in vitro. Results: In vitro tracer uptake increased with increasing vector concentration and over time. It was comparable to cells infected with adenovirus expressing only wild-type HSV1-tk (reporter probe: 14C-FIAU) or mutant HSV1-sr39tk (reporter probe: 18F-FHBG) . No significant uptake was observed in cells infected with adenovirus expressing VEGF alone. With increasing vector concentration, Ad4tk-infected cells increasingly released VEGF into medium. VEGF production correlated significantly with cellular reporter probe uptake (r = 0.93; P = 0.0003). Conclusion: The usefulness of a vector coexpressing HSV1-tk and VEGF for noninvasive imaging of expression of a therapeutic transgene has been demonstrated in vitro. This approach may allow for future in vivo monitoring of cardiac angiogenesis gene therapy.

AB - Coexpression of a reporter gene and a therapeutic gene may allow for noninvasive monitoring of cardiac gene therapy. We sought to evaluate the usefulness of an adenoviral vector expressing mutant herpesviral thymidine kinase reporter gene (HSV1-sr39tk) and vascular endothelial growth factor (VEGF) 121 in independent expression cassettes (Ad4tk). Methods: Accumulation of 14C-2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FIAU) and 9-(4-18F-fluoro-3-hydroxymethylbutyl)guanine (FHBG) as reporter probes, and secretion of VEGF into medium, were determined for Ad4tk-infected H9c2 rat cardiac cells in vitro. Results: In vitro tracer uptake increased with increasing vector concentration and over time. It was comparable to cells infected with adenovirus expressing only wild-type HSV1-tk (reporter probe: 14C-FIAU) or mutant HSV1-sr39tk (reporter probe: 18F-FHBG) . No significant uptake was observed in cells infected with adenovirus expressing VEGF alone. With increasing vector concentration, Ad4tk-infected cells increasingly released VEGF into medium. VEGF production correlated significantly with cellular reporter probe uptake (r = 0.93; P = 0.0003). Conclusion: The usefulness of a vector coexpressing HSV1-tk and VEGF for noninvasive imaging of expression of a therapeutic transgene has been demonstrated in vitro. This approach may allow for future in vivo monitoring of cardiac angiogenesis gene therapy.

KW - Gene therapy

KW - Heart

KW - Hsv1-tk

KW - Reporter genes

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=11144307071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144307071&partnerID=8YFLogxK

M3 - Article

C2 - 15471843

AN - SCOPUS:11144307071

VL - 45

SP - 1743

EP - 1746

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 10

ER -